Obesity
The latest scientific research and clinical treatment advances around obesity and weight loss.
Top News
-
Not all fiber is created equal, and one particular type – which is most highly concentrated in common breakfast oats – may trigger the same beneficial metabolic functions that GLP-1 agonists like Ozempic do, without the price tag or side-effects. -
After screening 20,000 protein-encoding genes in the human body, Stanford researchers have identified a naturally occurring molecule that works like semaglutide, most popularly known as Ozempic, to put the brakes on appetite and weight gain. -
There's a growing body of evidence that gold nanoparticles can trigger significant weight loss that targets fat, without affecting muscles, plus heal organs and improve blood-glucose levels. A new study makes a strong case for the first-ever human trial.
Load More
Latest News
-
June 25, 2025 | Abhimanyu GhoshalA new drug from pharma company Amgen shows promise as a powerful treatment for obesity. With just a once-monthly shot of 'MariTide,' participants in the study lost as much as 16% of their body weight over the course of a year. -
June 23, 2025 | Bronwyn ThompsonOver the weekend, Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing what appears to be a strategic "something for everyone" plan of attack from the pharmaceutical giant. -
June 21, 2025 | Bronwyn ThompsonA novel weight loss drug in the same class as semaglutide has successfully met its targets in the largest clinical trial yet, with nearly 90% of participants losing at least 5% of their body weight. The results strengthen its case for FDA approval. -
May 12, 2025 | Paul McClureThe first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference. And one clearly comes out on top. -
May 07, 2025 | Bronwyn ThompsonFollowing on from a remarkable study in mice, scientists have now confirmed that silencing a certain protein in muscle tissue leads to energy-deprived human cells seeking out fat for fuel, while blocking the body's ability to store extra fat cells. -
May 05, 2025 | Bronwyn ThompsonThe first once-daily oral GLP-1 medication could be on shelves by this time next year, making the weight-loss drug easier to take and potentially cheaper. In the race to be the first, Novo Nordisk has scored a huge win, while Pfizer has failed again. -
March 26, 2025 | Paul McClureExtracts made from parts of the cashew plant that are usually thrown away when the nuts are processed commercially were found to significantly limit the development of fat cells and the accumulation of fat, according to new research. -
March 24, 2025 | Bronwyn ThompsonIt was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks like we'll have the next generation of these breakthrough weight loss and diabetes medicines on shelves by early next year. -
February 27, 2025 | Michael IrvingScientists in China have found a new potential drug target for weight loss. Blocking a protein called CD44 has been shown to protect against obesity in mice on a high-fat diet, specifically by suppressing the formation of white fat cells. -
February 12, 2025 | Paul McClureA new study has confirmed that weight loss or bariatric surgery is safe and very effective, and, for a large percentage of people who were diabetic before the surgery, meant that they didn’t require diabetes medication five years after. -
February 06, 2025 | Bronwyn ThompsonScientists remain puzzled as to why some people taking popular weight loss and diabetes medications like Ozempic and Wegovy are losing their vision suddenly, highlighting that there's still so much we don't know about this life-changing class of drugs. -
January 29, 2025 | Bronwyn ThompsonA brand new candidate for weight-loss treatment is on the table, with scientists uncovering for the first time how a hormone produced by the hypothalamus during sleep has a direct impact on appetite regulation and metabolism. -
January 14, 2025 | Paul McClureIs obesity a disease or a risk factor for disease? It's a contentious question. In a new report, the Global Commission on Clinical Obesity strives to settle the enduring debate, introducing a new framework that seeks to redefine obesity. -
December 25, 2024 | Paul McClureNearly half of US adults admit they’d take one of the newer, injectable weight loss drugs; that number falls significantly when they learn the weight might come back when the meds are stopped. It’s something that has medical professionals concerned. -
December 08, 2024 | Paul McClureBalloons that trick the stomach into feeling full have long been used for weight loss. But, they become less effective the longer they stay inflated. Engineers have devised a balloon that inflates and deflates on demand – it reduced food intake by 60%.
Load More